Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-05 2:03 pm Purchase | 2025-11-28 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 9,095,680 11.600% | 3,375,922 (+59.02%) | Filing History |
| 2025-08-06 11:51 am Sale | 2025-06-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 5,719,758 6.700% | -898,539 (-13.58%) | Filing History |
| 2025-05-14 6:21 pm Purchase | 2025-03-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | JPM Partners LLC | 8,876,453 10.100% | 713,539 (+8.74%) | Filing History |
| 2025-04-23 8:14 pm Sale | 2025-03-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 6,082,350 7.100% | -3,361,537 (-35.59%) | Filing History |
| 2025-04-17 12:23 pm Purchase | 2025-04-16 | 13D | Atea Pharmaceuticals, Inc. AVIR | Radoff Bradley Louis | 3,380,100 4.000% | 275,000 (+8.86%) | Filing History |
| 2025-03-21 11:58 am Purchase | 2025-03-20 | 13D | Atea Pharmaceuticals, Inc. AVIR | Radoff Bradley Louis | 3,105,100 3.600% | 285,100 (+10.11%) | Filing History |
| 2025-03-04 09:27 am Purchase | 2025-02-27 | 13D | Atea Pharmaceuticals, Inc. AVIR | Radoff Bradley Louis | 2,820,000 3.300% | 2,820,000 (New Position) | Filing History |
| 2025-02-14 12:47 pm Sale | 2024-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 3,341,653 4.000% | -2,100,243 (-38.59%) | Filing History |
| 2024-12-16 09:50 am Purchase | 2024-12-13 | 13D | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 7,216,312 8.500% | 1,614,233 (+28.81%) | Filing History |
| 2024-11-15 10:34 am Sale | 2024-09-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 5,441,896 6.400% | -1,553,965 (-22.21%) | Filing History |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 6,618,297 7.839% | 1,267,638 (+23.69%) | Filing History |
| 2024-02-15 11:35 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-15 09:15 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 8:02 pm Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 811,000 (+13.11%) | Filing History |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | Atea Pharmaceuticals, Inc. AVIR | The Vanguard Group | 4,599,710 5.510% | -1,489,812 (-24.47%) | Filing History |
| 2024-02-13 4:30 pm Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | JPM Partners LLC | 8,162,914 9.600% | 688,032 (+9.20%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 5,350,659 6.412% | -1,723,628 (-24.36%) | Filing History |
| 2024-02-07 09:25 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 5,602,079 6.700% | 0 (Unchanged) | Filing History |
| 2024-02-07 09:14 am Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 5,602,079 6.700% | 1,418,434 (+33.90%) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 9,443,887 11.300% | 605,872 (+6.86%) | Filing History |